Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Working Capital/Sales

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results

GENPHARMASEC Last 5 Year Working Capital/Sales History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Working Capital/Sales(x) 0.811.511.791.091.62

What is the latest Working Capital/Sales ratio of GENPHARMASEC ?

The latest Working Capital/Sales ratio of GENPHARMASEC is 0.81 based on Mar2024 Standalone results.
Year Working Capital/Sales
Mar20240.81
Mar20231.51
Mar20221.79
Mar20211.09
Mar20201.62

How is Working Capital/Sales of GENPHARMASEC Trending?

Years Working Capital/Sales % Change
Mar2024 0.81
-46.36
Mar2023 1.51
-15.64
Mar2022 1.79
64.22
Mar2021 1.09
-32.72
Mar2020 1.62 -

Other Financial Ratios of GENPHARMASEC


Compare Working Capital/Sales ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹124.0 Cr -10.8% -27.3% -53.6% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹7,990.1 Cr 4.7% -7.4% 91.8% Stock Analytics
KIRI INDUSTRIES ₹3,561.9 Cr 7.7% 10% 59.2% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹2,402.9 Cr 2% 2% 17.7% Stock Analytics
BHAGERIA INDUSTRIES ₹864.6 Cr -2.3% -3.1% 25.1% Stock Analytics
BODAL CHEMICALS ₹801.8 Cr 4.6% -4% -23.2% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

-10.8%

-27.3%

-53.6%

SENSEX

0.5%

0.3%

7.9%


You may also like the below Video Courses